HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM.

Latife BozkurtChristian S GöblKaroline LeitnerGiovanni PaciniAlexandra Kautzky-Willer

Published in: BMJ open diabetes research & care (2021)

HbA1c measured before recommended routine screening period reflects early pathophysiological derangements in beta-cell function and glucose disposal that are characteristic of GDM development and may be useful in early risk stratification.

Keyphrases

single cell
polycystic ovary syndrome
oxidative stress
cell therapy
clinical practice
stem cells
type diabetes
blood pressure
pregnant women
bone marrow
municipal solid waste
metabolic syndrome
risk assessment
mesenchymal stem cells
pregnancy outcomes
cervical cancer screening